MedPath

FRISIUM TABLET 10MG

FRISIUM TABLET 10MG

Discontinued
DIN Number

02221799

Drug Class

Human

Market Date

Mar 24, 1997

Company
HC

Lundbeck Pharmaceuticals LLC

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02221799
AIG Number0114637001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Targeted (CDSA IV)
A
ATC Code
N05BA09 CLOBAZAM
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:12.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

CLOBAZAMActive
Strength: 10 MG
Monograph: CLOBAZAM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.